Modification of alterations in cardiac function and sarcoplasmic reticulum by astragaloside IV in myocardial injury in vivo

European Journal of Pharmacology

Volumn 568, Issue 1-3, 2007, Pages 203-212

  Xu, Xiao Le ^a   Ji, Hui ^a   Gu, Shu Yi ^a   Shao, Qin ^a   Huang, Qiu Ju ^a   Cheng, Yan Ping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Astragaloside IV; Cardiac function; Sarcoplasmic reticulum Ca2+ transport; Sarcoplasmic reticulum membrane remodeling

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ASTRAGALOSIDE IV; ASTRAGALUS MEMBRANACEUS EXTRACT; CALCIUM ION; CREATINE KINASE; ISOPRENALINE; LACTATE DEHYDROGENASE; MALONALDEHYDE; PHOSPHOLAMBAN; PROPRANOLOL; SAPONIN DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART PROTECTION; HEMODYNAMICS; HISTOPATHOLOGY; IN VIVO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CREATINE KINASE; DRUGS, CHINESE HERBAL; HEART; HEART INJURIES; HEART RATE; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; MYOCARDIUM; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SAPONINS; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SUPEROXIDE DISMUTASE; TRITERPENES;

EID: 34250835018     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.04.007     Document Type: Article

References (39)

1. Acikel M., Buyukokuroglu M.E., Erdogan F., Aksoy H., Bozkurt E., and Senocak H. Protective effects of dantrolene against myocardial injury induced by isoproterenol in rats: biochemical and histological findings. Int. J. Cardiol. 98 (2005) 389-394
2. 2+-ATPase: advances during the past decade and prospects for the coming decade. Jpn. Heart J. 41 (2000) 1-13
3. Bassani J.W., Bassani R.A., and Bers D.M. Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J. Physiol. 476 (1994) 279-293
4. Chen L.X., Liao J.Z., and Guo W.Q. Effects of Astragalus membranaceus on left ventricular function and oxygen free radical in acute myocardial infarction patients and mechanism of its cardiotonic action. Chin. J. Integr. Tradit. West. Med. 15 (1995) 141-143
5. Chen X.J., Meng D., Feng L., Bian Y.Y., Li P., Yang D., Cao K.J., and Zhang J.N. Protective effect of astragalosides on myocardial injury by isoproterenol in SD rats. Am. J. Chin. Med. 34 (2006) 1015-1025
6. 2+-handling in failing human myocardium. J. Mol. Cell. Cardiol. 33 (2001) 1345-1353
7. Frank K.F., Bolck B., Brixius K., Kranias E.G., and Schwinger R.H. Modulation of SERCA: implications for the failing human heart. Basic Res. Cardiol. 97 (2002) 72-78
8. Giannni D., Chan J., Gwathmey J.K., del Monte F., and Hajjar R.J. SERCA2a in heart failure: role and therapeutic prospects. J. Bioenerg. Biomembranes 37 (2005) 375-380
9. Grimm D., Elsner D., Schunkert H., Pfeifer M., Griese D., Bruckschlegel G., Muders F., Riegger G.A., and Kromer E.P. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc. Res. 37 (1998) 91-100
10. Han L., and Chen K. Progress of experimental pharmacologic study on the effect of Astragaus on the cardiac vascular system. Chin. J. Integr. Tradit. West. Med. 20 (2000) 234-237
11. Jia Y.X., Pan C.S., Zhang J., Geng B., Zhao J., Gerns H., Yang J., Chang J.K., Tang C.S., and Qi Y.F. Apelin protects myocardial injury induced by isoproterenol in rats. Regul. Pept. 133 (2006) 147-154
12. 2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes. Eur. J. Pharmacol. 535 (2006) 212-219
13. Kourie J.I. Interaction of reactive oxygen species with ion transport mechanisms. Am. J. Physiol. 275 (1998) C1-C24
14. Koss K.L., and Kranias E.G. Phospholamban: a prominent regulator of myocardial contractility. Circ. Res. 79 (1996) 1059-1063
15. Kuschel M., Karczewski P., Hempel P., Schlegel W.P., Krause E.G., and Bartel S. Ser16 prevails over Thr17 phospholamban phosphorylation in the beta-adrenergic regulation of cardiac relaxation. Am. J. Physiol. 276 (1999) H1625-H1633
16. Lei Z.Y. Effect of Astragalus membranaceus on cardiovascular system. Chin. J. Integr. Tradit. West. Med. 13 (1993) 443-446
17. Li Z.P., and Cao Q. Effects of astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats. Acta Pharmacol. Sin. 23 (2002) 898-904
18. Linck B., Boknik P., Baba H.A., Eschenhagen T., Haverkamp U., Jackel E., Jones L.R., Kirchhefer U., Knapp J., Laer S., Muller F.U., Schmitz W., Scholz H., Syska A., Vahlensieck U., and Neumann J. Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(+)-ATPase in mammalian ventricle. J. Pharmacol. Exp. Ther. 286 (1998) 531-538
19. Ma Z., and Yang Z. Scavenging effects of Astragalus and Gynostemma pentaphyllum with its product on O2-. and .OH. J. Chin. Med. Mater. 22 (1999) 303-306
20. Meyer M., Schillinger W., Pieske B., Holubarsch C., Heilmann C., Posival H., Kuwajima G., Mikoshiba K., Just H., Hasenfuss G., et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 92 (1995) 778-784
21. Miller A.L. Botanical influences on cardiovascular disease. Altern. Med. Rev. 3 (1998) 422-431
22. Plank D.M., Yatani A., Ritsu H., Witt S., Glascock B., Lalli M.J., Periasamy M., Fiset C., Benkusky N., Valdivia H.H., and Sussman M.A. Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade. Am. J. Physiol.: Heart Circ. Physiol. 285 (2003) H305-H315
23. Rao P.S., Lukes J.J., Ayres S.M., and Mueller H. New manual and automated method for determining activity of creatine kinase isoenzyme MB, by use of dithiothreitol: clinical applications. Clin. Chem. 21 (1975) 1612-1618
24. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 17 (1985) 291-306
25. Rona G., Chappel C.I., Balazs T., and Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. A.M.A. Arch. Pathol. 67 (1959) 443-455
26. Sande J.B., Sjaastad I., Hoen I.B., Bokenes J., Tonnessen T., Holt E., Lunde P.K., and Christensen G. Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc. Res. 53 (2002) 382-391
27. Satoh S., Ueda Y., Suematsu N., Oyama J., Kadokami T., Sugano M., Yoshikawa Y., and Makino N. Beneficial effects of angiotensin-converting enzyme inhibition on sarcoplasmic reticulum function in the failing heart of the Dahl rat. Circ. J. 67 (2003) 705-711
28. Schmidt U., Hajjar R.J., Helm P.A., Kim C.S., Doye A.A., and Gwathmey J.K. Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure. J. Mol. Cell. Cardiol. 30 (1998) 1929-1937
29. Schmidt A.G., Edes I., and Kranias E.G. Phospholamban: a promising therapeutic target in heart failure?. Cardiovasc. Drugs Ther. 15 (2001) 387-396
30. Singh R.B., Chohan P.K., Dhalla N.S., and Netticadan T. The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart. J. Mol. Cell. Cardiol. 37 (2004) 101-110
31. Sjaastad I., Wasserstrom J.A., and Sejersted O.M. Heart failure-a challenge to our current concepts of excitation-contraction coupling. J. Physiol. 546 (2003) 33-47
32. Sun Y.L., Hu S.J., Wang L.H., Hu Y., and Zhou J.Y. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats. Chest 128 (2005) 1812-1821
33. Temsah R.M., Dyck C., Netticadan T., Chapman D., Elimban V., and Dhalla N.S. Effect of beta-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart. J. Pharmacol. Exp. Ther. 293 (2000) 15-23
34. Werthamer S., Freiberg A., and Amaral L. Quantitation of lactate dehydrogenase isoenzyme patterns of the developing human fetus. Clin. Chim. Acta 45 (1973) 5-8
35. Xia Z., Liu M., Wu Y., Sharma V., Luo T., Ouyang J., and McNeill J.H. N-acetylcysteine attenuates TNF-alpha-induced human vascular endothelial cell apoptosis and restores eNOS expression. Eur. J. Pharmacol. 550 (2006) 134-142
36. Xie Y., Zhu Y., Zhu W.Z., Chen L., Zhou Z.N., Yuan W.J., and Yang H.T. Role of dual-site phospholamban phosphorylation in intermittent hypoxia-induced cardioprotection against ischemia-reperfusion injury. Am. J. Physiol.: Heart Circ. Physiol. 288 (2005) H2594-H2602
37. Zhang W.D., Chen H., Zhang C., Liu R.H., Li H.L., and Chen H.Z. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta. Med. 72 (2006) 4-8
38. Zhou J.Y., Fan Y., Kong J.L., Wu D.Z., and Hu Z.B. Effects of components isolated from Astragalus membranaceus Bunge on cardiac function injured by myocardial ischemia reperfusion in rats. China J. Chin. Mater. Med. 25 (2000) 300-302
39. Zhong Y., Ahmed S., Grupp I.L., and Matlib M.A. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am. J. Physiol.: Heart Circ. Physiol. 281 (2001) H1137-H1147